Sacramento Bee examines oral peptide strips and their needle-free claims
The report looks at how FDA officials and researchers view sublingual and buccal peptide products marketed as alternatives to injection.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 7 18:00 ETSource: Sacramento Bee
The wire
- 01A Sacramento Bee report examines oral peptide strips sold on claims of needle-free delivery and what regulators and researchers say about them.
- 02Clinics and telehealth sellers increasingly offer sublingual peptide formats, so the question of whether these routes deliver meaningful absorption matters to prescribers and patients.
- 03Peptide bioavailability by oral routes is generally poor without specialised formulation, and the coverage does not point to approved products in this category.
From the source
Read at amp.sacbee.comOral peptide strips promise needle-free delivery, but what do the FDA and researchers say?
